Global /China /Healthcare /Drug Manufacturers - General /300705

Hunan Jiudian Pharmaceutical Co., Ltd.

300705

• SHE: 300705 • Delayed

12.85CNY -0.7%

1.90 USD

As of 16 June 2026, Hunan Jiudian Pharmaceutical Co., Ltd. has a market cap of $944.23M USD, ranking #11039 globally and #3140 in China. It ranks #996 in the Healthcare sector, and #372 in the Drug Manufacturers - General industry.

Global Rank

11039

Country Rank

3140

Sector Rank

996

Industry Rank

372

Key Stats

Market Cap

$944.23MUSD

6.39B CNY

Enterprise Value

$959.54MUSD

6.49B CNY

Revenue (TTM)

$444.53MUSD

3.01B CNY

EBITDA (TTM)

$94.19MUSD

637.45M CNY

Net Income (TTM)

$59.63MUSD

403.78M CNY

EBITDA Margin

21%

Profit Margin

13%

PE Ratio

16.1

Forward PE

8.8

PS Ratio

2.1

PB Ratio

2.3

EV/EBITDA

10.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yang Yang open_in_new

Employees

2,221

Founded

2001

Website

hnjiudian.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.7%	-6.2%	-7.3%	-17%	-23%	-14%	-19%	-31%	-16%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300705 湖南九典制药股份有限公司 Class A ISIN: CNE1000034Z6 Shares Out.: Shares Outstanding: 494.11M¹ Shares Float: 352.726M² TV: TradingView: SZSE: 300705 SA: Stock Analysis: SHE: 300705 YF: Yahoo Finance: 300705.SZ GF: Google Finance: SHE: 300705 BA: Barron's: 300705 MS: Morningstar: XSHE: 300705	12.85 CNY	TV: TradingView: SZSE: 300705 SA: Stock Analysis: SHE: 300705 YF: Yahoo Finance: 300705.SZ GF: Google Finance: SHE: 300705 BA: Barron's: 300705 MS: Morningstar: XSHE: 300705

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hunan Jiudian Pharmaceutical Co., Ltd.

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and breathing and anti-allergy. In addition, it provides CMO/CDMO services. The company was founded in 2001 and is based in Changsha, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 81K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 58K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 38K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 34K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 31K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 29K%	20.5	Switzerland

chevron_leftBack